CERA

unofficial impact factor 1.46
Search for
Advanced search
Cost Effectiveness and Resource Allocation
Tools
Open Access Highly Access Email this article to a friend

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

Gord Blackhouse*, Kathryn Gaebel, Feng Xie, Kaitryn Campbell, Nazila Assasi, Jean-Eric Tarride, Daria O'Reilly, Colin Chalk, Mitchell Levine and Ron Goeree

Cost Effectiveness and Resource Allocation 2010, 8:14 doi:10.1186/1478-7547-8-14

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.